Get Real Time Here
| Open12.520 | Close- |
| Vol / Avg.127.019K / 387.666K | Mkt Cap250.349M |
| Day Range11.960 - 12.610 | 52 Wk Range11.560 - 62.060 |
Enanta Pharma Stock (NASDAQ:ENTA), Quotes and News Summary
Enanta Pharma Stock (NASDAQ: ENTA) stock price, news, charts, stock research, profile.
| Open12.520 | Close- |
| Vol / Avg.127.019K / 387.666K | Mkt Cap250.349M |
| Day Range11.960 - 12.610 | 52 Wk Range11.560 - 62.060 |
Earnings
see more| Q4 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -2.330 | -1.860 | 0.4700 | ||||
| REV | 18.060M | 18.892M | 832.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-19 | HC Wainwright & Co. | Ed Arce | Reiterates | BuyBuy | Maintains | - | 48.00 |
| 2023-08-09 | Oppenheimer | Jay Olson | Maintains | PerformPerform | Lowers | 30.00 | 25.00 |
| 2023-08-08 | HC Wainwright & Co. | Ed Arce | Reiterates | BuyBuy | Maintains | - | 48.00 |
| 2023-08-08 | RBC Capital | Brian Abrahams | Reiterates | Sector PerformSector Perform | Maintains | - | 25.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ENTA | Enanta Pharma | -5.78% | 250.3M |
| MGNX | Macrogenics | 1.87% | 286.5M |
| ZURA | Zura Bio | 2.58% | 268.8M |
| SPRY | ARS Pharmaceuticals | 22.95% | 343.1M |
| HUMA | Humacyte | 2.04% | 310.3M |
How do I buy Enanta Pharma (ENTA) stock?
You can purchase shares of Enanta Pharma (NASDAQ: ENTA) through any online brokerage.
Who are Enanta Pharma's (ENTA) competitors?
Other companies in Enanta Pharma’s space includes: Macrogenics (NASDAQ:MGNX), Zura Bio (NASDAQ:ZURA), ARS Pharmaceuticals (NASDAQ:SPRY), Humacyte (NASDAQ:HUMA) and Inozyme Pharma (NASDAQ:INZY).
What is the target price for Enanta Pharma (ENTA) stock?
The latest price target for Enanta Pharma (NASDAQ: ENTA) was reported by HC Wainwright & Co. on Tuesday, September 19, 2023. The analyst firm set a price target for 48.00 expecting ENTA to rise to within 12 months (a possible 303.70% upside). 17 analyst firms have reported ratings in the last year.
Current Stock Price for Enanta Pharma (ENTA)?
The stock price for Enanta Pharma (NASDAQ: ENTA) is $11.89 last updated Today at September 21, 2023 at 6:27 PM UTC.
Does Enanta Pharma (ENTA) pay a dividend?
There is no dividend information for Enanta Pharma.
When is Enanta Pharma (NASDAQ:ENTA) reporting earnings?
Enanta Pharma’s Q4 earnings are confirmed for Monday, November 20, 2023.
Is Enanta Pharma (ENTA) going to split?
There is no upcoming split for Enanta Pharma.
What sector and industry does Enanta Pharma (ENTA) operate in?
Enanta Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Enanta Pharma Stock (NASDAQ:ENTA), Quotes and News Summary
Enanta Pharma Stock (NASDAQ: ENTA) stock price, news, charts, stock research, profile.
| Open12.520 | Close- |
| Vol / Avg.127.019K / 387.666K | Mkt Cap250.349M |
| Day Range11.960 - 12.610 | 52 Wk Range11.560 - 62.060 |
Earnings
see more| Q4 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -2.330 | -1.860 | 0.4700 | ||||
| REV | 18.060M | 18.892M | 832.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-19 | HC Wainwright & Co. | Ed Arce | Reiterates | BuyBuy | Maintains | - | 48.00 |
| 2023-08-09 | Oppenheimer | Jay Olson | Maintains | PerformPerform | Lowers | 30.00 | 25.00 |
| 2023-08-08 | HC Wainwright & Co. | Ed Arce | Reiterates | BuyBuy | Maintains | - | 48.00 |
| 2023-08-08 | RBC Capital | Brian Abrahams | Reiterates | Sector PerformSector Perform | Maintains | - | 25.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ENTA | Enanta Pharma | -5.78% | 250.3M |
| MGNX | Macrogenics | 1.87% | 286.5M |
| ZURA | Zura Bio | 2.58% | 268.8M |
| SPRY | ARS Pharmaceuticals | 22.95% | 343.1M |
| HUMA | Humacyte | 2.04% | 310.3M |
How do I buy Enanta Pharma (ENTA) stock?
You can purchase shares of Enanta Pharma (NASDAQ: ENTA) through any online brokerage.
Who are Enanta Pharma's (ENTA) competitors?
Other companies in Enanta Pharma’s space includes: Macrogenics (NASDAQ:MGNX), Zura Bio (NASDAQ:ZURA), ARS Pharmaceuticals (NASDAQ:SPRY), Humacyte (NASDAQ:HUMA) and Inozyme Pharma (NASDAQ:INZY).
What is the target price for Enanta Pharma (ENTA) stock?
The latest price target for Enanta Pharma (NASDAQ: ENTA) was reported by HC Wainwright & Co. on Tuesday, September 19, 2023. The analyst firm set a price target for 48.00 expecting ENTA to rise to within 12 months (a possible 303.70% upside). 17 analyst firms have reported ratings in the last year.
Current Stock Price for Enanta Pharma (ENTA)?
The stock price for Enanta Pharma (NASDAQ: ENTA) is $11.89 last updated Today at September 21, 2023 at 6:27 PM UTC.
Does Enanta Pharma (ENTA) pay a dividend?
There is no dividend information for Enanta Pharma.
When is Enanta Pharma (NASDAQ:ENTA) reporting earnings?
Enanta Pharma’s Q4 earnings are confirmed for Monday, November 20, 2023.
Is Enanta Pharma (ENTA) going to split?
There is no upcoming split for Enanta Pharma.
What sector and industry does Enanta Pharma (ENTA) operate in?
Enanta Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Enanta Pharma Stock (NASDAQ:ENTA), Quotes and News Summary
Enanta Pharma Stock (NASDAQ: ENTA) stock price, news, charts, stock research, profile.
| Open12.520 | Close- |
| Vol / Avg.127.019K / 387.666K | Mkt Cap250.349M |
| Day Range11.960 - 12.610 | 52 Wk Range11.560 - 62.060 |
Earnings
see more| Q4 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -2.330 | -1.860 | 0.4700 | ||||
| REV | 18.060M | 18.892M | 832.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-19 | HC Wainwright & Co. | Ed Arce | Reiterates | BuyBuy | Maintains | - | 48.00 |
| 2023-08-09 | Oppenheimer | Jay Olson | Maintains | PerformPerform | Lowers | 30.00 | 25.00 |
| 2023-08-08 | HC Wainwright & Co. | Ed Arce | Reiterates | BuyBuy | Maintains | - | 48.00 |
| 2023-08-08 | RBC Capital | Brian Abrahams | Reiterates | Sector PerformSector Perform | Maintains | - | 25.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ENTA | Enanta Pharma | -5.78% | 250.3M |
| MGNX | Macrogenics | 1.87% | 286.5M |
| ZURA | Zura Bio | 2.58% | 268.8M |
| SPRY | ARS Pharmaceuticals | 22.95% | 343.1M |
| HUMA | Humacyte | 2.04% | 310.3M |
How do I buy Enanta Pharma (ENTA) stock?
You can purchase shares of Enanta Pharma (NASDAQ: ENTA) through any online brokerage.
Who are Enanta Pharma's (ENTA) competitors?
Other companies in Enanta Pharma’s space includes: Macrogenics (NASDAQ:MGNX), Zura Bio (NASDAQ:ZURA), ARS Pharmaceuticals (NASDAQ:SPRY), Humacyte (NASDAQ:HUMA) and Inozyme Pharma (NASDAQ:INZY).
What is the target price for Enanta Pharma (ENTA) stock?
The latest price target for Enanta Pharma (NASDAQ: ENTA) was reported by HC Wainwright & Co. on Tuesday, September 19, 2023. The analyst firm set a price target for 48.00 expecting ENTA to rise to within 12 months (a possible 303.70% upside). 17 analyst firms have reported ratings in the last year.
Current Stock Price for Enanta Pharma (ENTA)?
The stock price for Enanta Pharma (NASDAQ: ENTA) is $11.89 last updated Today at September 21, 2023 at 6:27 PM UTC.
Does Enanta Pharma (ENTA) pay a dividend?
There is no dividend information for Enanta Pharma.
When is Enanta Pharma (NASDAQ:ENTA) reporting earnings?
Enanta Pharma’s Q4 earnings are confirmed for Monday, November 20, 2023.
Is Enanta Pharma (ENTA) going to split?
There is no upcoming split for Enanta Pharma.
What sector and industry does Enanta Pharma (ENTA) operate in?
Enanta Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Enanta Pharma Stock (NASDAQ:ENTA), Quotes and News Summary
Enanta Pharma Stock (NASDAQ: ENTA) stock price, news, charts, stock research, profile.
| Open12.520 | Close- |
| Vol / Avg.127.019K / 387.666K | Mkt Cap250.349M |
| Day Range11.960 - 12.610 | 52 Wk Range11.560 - 62.060 |
Earnings
see more| Q4 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -2.330 | -1.860 | 0.4700 | ||||
| REV | 18.060M | 18.892M | 832.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-19 | HC Wainwright & Co. | Ed Arce | Reiterates | BuyBuy | Maintains | - | 48.00 |
| 2023-08-09 | Oppenheimer | Jay Olson | Maintains | PerformPerform | Lowers | 30.00 | 25.00 |
| 2023-08-08 | HC Wainwright & Co. | Ed Arce | Reiterates | BuyBuy | Maintains | - | 48.00 |
| 2023-08-08 | RBC Capital | Brian Abrahams | Reiterates | Sector PerformSector Perform | Maintains | - | 25.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ENTA | Enanta Pharma | -5.78% | 250.3M |
| MGNX | Macrogenics | 1.87% | 286.5M |
| ZURA | Zura Bio | 2.58% | 268.8M |
| SPRY | ARS Pharmaceuticals | 22.95% | 343.1M |
| HUMA | Humacyte | 2.04% | 310.3M |
How do I buy Enanta Pharma (ENTA) stock?
You can purchase shares of Enanta Pharma (NASDAQ: ENTA) through any online brokerage.
Who are Enanta Pharma's (ENTA) competitors?
Other companies in Enanta Pharma’s space includes: Macrogenics (NASDAQ:MGNX), Zura Bio (NASDAQ:ZURA), ARS Pharmaceuticals (NASDAQ:SPRY), Humacyte (NASDAQ:HUMA) and Inozyme Pharma (NASDAQ:INZY).
What is the target price for Enanta Pharma (ENTA) stock?
The latest price target for Enanta Pharma (NASDAQ: ENTA) was reported by HC Wainwright & Co. on Tuesday, September 19, 2023. The analyst firm set a price target for 48.00 expecting ENTA to rise to within 12 months (a possible 303.70% upside). 17 analyst firms have reported ratings in the last year.
Current Stock Price for Enanta Pharma (ENTA)?
The stock price for Enanta Pharma (NASDAQ: ENTA) is $11.89 last updated Today at September 21, 2023 at 6:27 PM UTC.
Does Enanta Pharma (ENTA) pay a dividend?
There is no dividend information for Enanta Pharma.
When is Enanta Pharma (NASDAQ:ENTA) reporting earnings?
Enanta Pharma’s Q4 earnings are confirmed for Monday, November 20, 2023.
Is Enanta Pharma (ENTA) going to split?
There is no upcoming split for Enanta Pharma.
What sector and industry does Enanta Pharma (ENTA) operate in?
Enanta Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Enanta Pharma Stock (NASDAQ:ENTA), Quotes and News Summary
Enanta Pharma Stock (NASDAQ: ENTA) stock price, news, charts, stock research, profile.
| Open12.520 | Close- |
| Vol / Avg.127.019K / 387.666K | Mkt Cap250.349M |
| Day Range11.960 - 12.610 | 52 Wk Range11.560 - 62.060 |
Earnings
see more| Q4 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -2.330 | -1.860 | 0.4700 | ||||
| REV | 18.060M | 18.892M | 832.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-19 | HC Wainwright & Co. | Ed Arce | Reiterates | BuyBuy | Maintains | - | 48.00 |
| 2023-08-09 | Oppenheimer | Jay Olson | Maintains | PerformPerform | Lowers | 30.00 | 25.00 |
| 2023-08-08 | HC Wainwright & Co. | Ed Arce | Reiterates | BuyBuy | Maintains | - | 48.00 |
| 2023-08-08 | RBC Capital | Brian Abrahams | Reiterates | Sector PerformSector Perform | Maintains | - | 25.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ENTA | Enanta Pharma | -5.78% | 250.3M |
| MGNX | Macrogenics | 1.87% | 286.5M |
| ZURA | Zura Bio | 2.58% | 268.8M |
| SPRY | ARS Pharmaceuticals | 22.95% | 343.1M |
| HUMA | Humacyte | 2.04% | 310.3M |
How do I buy Enanta Pharma (ENTA) stock?
You can purchase shares of Enanta Pharma (NASDAQ: ENTA) through any online brokerage.
Who are Enanta Pharma's (ENTA) competitors?
Other companies in Enanta Pharma’s space includes: Macrogenics (NASDAQ:MGNX), Zura Bio (NASDAQ:ZURA), ARS Pharmaceuticals (NASDAQ:SPRY), Humacyte (NASDAQ:HUMA) and Inozyme Pharma (NASDAQ:INZY).
What is the target price for Enanta Pharma (ENTA) stock?
The latest price target for Enanta Pharma (NASDAQ: ENTA) was reported by HC Wainwright & Co. on Tuesday, September 19, 2023. The analyst firm set a price target for 48.00 expecting ENTA to rise to within 12 months (a possible 303.70% upside). 17 analyst firms have reported ratings in the last year.
Current Stock Price for Enanta Pharma (ENTA)?
The stock price for Enanta Pharma (NASDAQ: ENTA) is $11.89 last updated Today at September 21, 2023 at 6:27 PM UTC.
Does Enanta Pharma (ENTA) pay a dividend?
There is no dividend information for Enanta Pharma.
When is Enanta Pharma (NASDAQ:ENTA) reporting earnings?
Enanta Pharma’s Q4 earnings are confirmed for Monday, November 20, 2023.
Is Enanta Pharma (ENTA) going to split?
There is no upcoming split for Enanta Pharma.
What sector and industry does Enanta Pharma (ENTA) operate in?
Enanta Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Enanta Pharma Stock (NASDAQ:ENTA), Quotes and News Summary
Enanta Pharma Stock (NASDAQ: ENTA) stock price, news, charts, stock research, profile.
| Open12.520 | Close- |
| Vol / Avg.127.019K / 387.666K | Mkt Cap250.349M |
| Day Range11.960 - 12.610 | 52 Wk Range11.560 - 62.060 |
Earnings
see more| Q4 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -2.330 | -1.860 | 0.4700 | ||||
| REV | 18.060M | 18.892M | 832.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-19 | HC Wainwright & Co. | Ed Arce | Reiterates | BuyBuy | Maintains | - | 48.00 |
| 2023-08-09 | Oppenheimer | Jay Olson | Maintains | PerformPerform | Lowers | 30.00 | 25.00 |
| 2023-08-08 | HC Wainwright & Co. | Ed Arce | Reiterates | BuyBuy | Maintains | - | 48.00 |
| 2023-08-08 | RBC Capital | Brian Abrahams | Reiterates | Sector PerformSector Perform | Maintains | - | 25.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ENTA | Enanta Pharma | -5.78% | 250.3M |
| MGNX | Macrogenics | 1.87% | 286.5M |
| ZURA | Zura Bio | 2.58% | 268.8M |
| SPRY | ARS Pharmaceuticals | 22.95% | 343.1M |
| HUMA | Humacyte | 2.04% | 310.3M |
How do I buy Enanta Pharma (ENTA) stock?
You can purchase shares of Enanta Pharma (NASDAQ: ENTA) through any online brokerage.
Who are Enanta Pharma's (ENTA) competitors?
Other companies in Enanta Pharma’s space includes: Macrogenics (NASDAQ:MGNX), Zura Bio (NASDAQ:ZURA), ARS Pharmaceuticals (NASDAQ:SPRY), Humacyte (NASDAQ:HUMA) and Inozyme Pharma (NASDAQ:INZY).
What is the target price for Enanta Pharma (ENTA) stock?
The latest price target for Enanta Pharma (NASDAQ: ENTA) was reported by HC Wainwright & Co. on Tuesday, September 19, 2023. The analyst firm set a price target for 48.00 expecting ENTA to rise to within 12 months (a possible 303.70% upside). 17 analyst firms have reported ratings in the last year.
Current Stock Price for Enanta Pharma (ENTA)?
The stock price for Enanta Pharma (NASDAQ: ENTA) is $11.89 last updated Today at September 21, 2023 at 6:27 PM UTC.
Does Enanta Pharma (ENTA) pay a dividend?
There is no dividend information for Enanta Pharma.
When is Enanta Pharma (NASDAQ:ENTA) reporting earnings?
Enanta Pharma’s Q4 earnings are confirmed for Monday, November 20, 2023.
Is Enanta Pharma (ENTA) going to split?
There is no upcoming split for Enanta Pharma.
What sector and industry does Enanta Pharma (ENTA) operate in?
Enanta Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Enanta Pharma Stock (NASDAQ:ENTA), Quotes and News Summary
Enanta Pharma Stock (NASDAQ: ENTA) stock price, news, charts, stock research, profile.
| Open12.520 | Close- |
| Vol / Avg.127.019K / 387.666K | Mkt Cap250.349M |
| Day Range11.960 - 12.610 | 52 Wk Range11.560 - 62.060 |
Earnings
see more| Q4 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -2.330 | -1.860 | 0.4700 | ||||
| REV | 18.060M | 18.892M | 832.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-19 | HC Wainwright & Co. | Ed Arce | Reiterates | BuyBuy | Maintains | - | 48.00 |
| 2023-08-09 | Oppenheimer | Jay Olson | Maintains | PerformPerform | Lowers | 30.00 | 25.00 |
| 2023-08-08 | HC Wainwright & Co. | Ed Arce | Reiterates | BuyBuy | Maintains | - | 48.00 |
| 2023-08-08 | RBC Capital | Brian Abrahams | Reiterates | Sector PerformSector Perform | Maintains | - | 25.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ENTA | Enanta Pharma | -5.78% | 250.3M |
| MGNX | Macrogenics | 1.87% | 286.5M |
| ZURA | Zura Bio | 2.58% | 268.8M |
| SPRY | ARS Pharmaceuticals | 22.95% | 343.1M |
| HUMA | Humacyte | 2.04% | 310.3M |
How do I buy Enanta Pharma (ENTA) stock?
You can purchase shares of Enanta Pharma (NASDAQ: ENTA) through any online brokerage.
Who are Enanta Pharma's (ENTA) competitors?
Other companies in Enanta Pharma’s space includes: Macrogenics (NASDAQ:MGNX), Zura Bio (NASDAQ:ZURA), ARS Pharmaceuticals (NASDAQ:SPRY), Humacyte (NASDAQ:HUMA) and Inozyme Pharma (NASDAQ:INZY).
What is the target price for Enanta Pharma (ENTA) stock?
The latest price target for Enanta Pharma (NASDAQ: ENTA) was reported by HC Wainwright & Co. on Tuesday, September 19, 2023. The analyst firm set a price target for 48.00 expecting ENTA to rise to within 12 months (a possible 303.70% upside). 17 analyst firms have reported ratings in the last year.
Current Stock Price for Enanta Pharma (ENTA)?
The stock price for Enanta Pharma (NASDAQ: ENTA) is $11.89 last updated Today at September 21, 2023 at 6:27 PM UTC.
Does Enanta Pharma (ENTA) pay a dividend?
There is no dividend information for Enanta Pharma.
When is Enanta Pharma (NASDAQ:ENTA) reporting earnings?
Enanta Pharma’s Q4 earnings are confirmed for Monday, November 20, 2023.
Is Enanta Pharma (ENTA) going to split?
There is no upcoming split for Enanta Pharma.
What sector and industry does Enanta Pharma (ENTA) operate in?
Enanta Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Enanta Pharma Stock (NASDAQ:ENTA), Quotes and News Summary
Enanta Pharma Stock (NASDAQ: ENTA) stock price, news, charts, stock research, profile.
| Open12.520 | Close- |
| Vol / Avg.127.019K / 387.666K | Mkt Cap250.349M |
| Day Range11.960 - 12.610 | 52 Wk Range11.560 - 62.060 |
Earnings
see more| Q4 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -2.330 | -1.860 | 0.4700 | ||||
| REV | 18.060M | 18.892M | 832.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-19 | HC Wainwright & Co. | Ed Arce | Reiterates | BuyBuy | Maintains | - | 48.00 |
| 2023-08-09 | Oppenheimer | Jay Olson | Maintains | PerformPerform | Lowers | 30.00 | 25.00 |
| 2023-08-08 | HC Wainwright & Co. | Ed Arce | Reiterates | BuyBuy | Maintains | - | 48.00 |
| 2023-08-08 | RBC Capital | Brian Abrahams | Reiterates | Sector PerformSector Perform | Maintains | - | 25.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ENTA | Enanta Pharma | -5.78% | 250.3M |
| MGNX | Macrogenics | 1.87% | 286.5M |
| ZURA | Zura Bio | 2.58% | 268.8M |
| SPRY | ARS Pharmaceuticals | 22.95% | 343.1M |
| HUMA | Humacyte | 2.04% | 310.3M |
How do I buy Enanta Pharma (ENTA) stock?
You can purchase shares of Enanta Pharma (NASDAQ: ENTA) through any online brokerage.
Who are Enanta Pharma's (ENTA) competitors?
Other companies in Enanta Pharma’s space includes: Macrogenics (NASDAQ:MGNX), Zura Bio (NASDAQ:ZURA), ARS Pharmaceuticals (NASDAQ:SPRY), Humacyte (NASDAQ:HUMA) and Inozyme Pharma (NASDAQ:INZY).
What is the target price for Enanta Pharma (ENTA) stock?
The latest price target for Enanta Pharma (NASDAQ: ENTA) was reported by HC Wainwright & Co. on Tuesday, September 19, 2023. The analyst firm set a price target for 48.00 expecting ENTA to rise to within 12 months (a possible 303.70% upside). 17 analyst firms have reported ratings in the last year.
Current Stock Price for Enanta Pharma (ENTA)?
The stock price for Enanta Pharma (NASDAQ: ENTA) is $11.89 last updated Today at September 21, 2023 at 6:27 PM UTC.
Does Enanta Pharma (ENTA) pay a dividend?
There is no dividend information for Enanta Pharma.
When is Enanta Pharma (NASDAQ:ENTA) reporting earnings?
Enanta Pharma’s Q4 earnings are confirmed for Monday, November 20, 2023.
Is Enanta Pharma (ENTA) going to split?
There is no upcoming split for Enanta Pharma.
What sector and industry does Enanta Pharma (ENTA) operate in?
Enanta Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Enanta Pharma Stock (NASDAQ:ENTA), Quotes and News Summary
Enanta Pharma Stock (NASDAQ: ENTA) stock price, news, charts, stock research, profile.
| Open12.520 | Close- |
| Vol / Avg.127.019K / 387.666K | Mkt Cap250.349M |
| Day Range11.960 - 12.610 | 52 Wk Range11.560 - 62.060 |
Earnings
see more| Q4 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -2.330 | -1.860 | 0.4700 | ||||
| REV | 18.060M | 18.892M | 832.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-19 | HC Wainwright & Co. | Ed Arce | Reiterates | BuyBuy | Maintains | - | 48.00 |
| 2023-08-09 | Oppenheimer | Jay Olson | Maintains | PerformPerform | Lowers | 30.00 | 25.00 |
| 2023-08-08 | HC Wainwright & Co. | Ed Arce | Reiterates | BuyBuy | Maintains | - | 48.00 |
| 2023-08-08 | RBC Capital | Brian Abrahams | Reiterates | Sector PerformSector Perform | Maintains | - | 25.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ENTA | Enanta Pharma | -5.78% | 250.3M |
| MGNX | Macrogenics | 1.87% | 286.5M |
| ZURA | Zura Bio | 2.58% | 268.8M |
| SPRY | ARS Pharmaceuticals | 22.95% | 343.1M |
| HUMA | Humacyte | 2.04% | 310.3M |
How do I buy Enanta Pharma (ENTA) stock?
You can purchase shares of Enanta Pharma (NASDAQ: ENTA) through any online brokerage.
Who are Enanta Pharma's (ENTA) competitors?
Other companies in Enanta Pharma’s space includes: Macrogenics (NASDAQ:MGNX), Zura Bio (NASDAQ:ZURA), ARS Pharmaceuticals (NASDAQ:SPRY), Humacyte (NASDAQ:HUMA) and Inozyme Pharma (NASDAQ:INZY).
What is the target price for Enanta Pharma (ENTA) stock?
The latest price target for Enanta Pharma (NASDAQ: ENTA) was reported by HC Wainwright & Co. on Tuesday, September 19, 2023. The analyst firm set a price target for 48.00 expecting ENTA to rise to within 12 months (a possible 303.70% upside). 17 analyst firms have reported ratings in the last year.
Current Stock Price for Enanta Pharma (ENTA)?
The stock price for Enanta Pharma (NASDAQ: ENTA) is $11.89 last updated Today at September 21, 2023 at 6:27 PM UTC.
Does Enanta Pharma (ENTA) pay a dividend?
There is no dividend information for Enanta Pharma.
When is Enanta Pharma (NASDAQ:ENTA) reporting earnings?
Enanta Pharma’s Q4 earnings are confirmed for Monday, November 20, 2023.
Is Enanta Pharma (ENTA) going to split?
There is no upcoming split for Enanta Pharma.
What sector and industry does Enanta Pharma (ENTA) operate in?
Enanta Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.